Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Stein, Joshua D ^a   Talwar, Nidhi ^a   Kang, Jae H ^b   Okereke, Olivia I ^b,c   Wiggs, Janey L ^d   Pasquale, Louis R ^b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DOSE RESPONSE; DRUG USE; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HUMAN; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; OPEN ANGLE GLAUCOMA; RISK ASSESSMENT; SOCIAL ASPECT; SOCIAL STATUS; UNITED STATES; BIOLOGICAL MODEL; CHEMICALLY INDUCED; HEALTH CARE DELIVERY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR;

ANIMALIA;

BUPROPION; DELIVERY OF HEALTH CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; RISK FACTORS; UNITED STATES;

EID: 84930009485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123682     Document Type: Article

References (34)

1. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol.2002; 120: 701-713. PMID: 12049574
2. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120: 1268-1279. PMID: 12365904
3. The Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998; 126: 498-505. PMID: 9780094
4. Inman DM, Horner PJ. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia. 2007; 55: 942-953. PMID: 17457855
5. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci. 2007; 48: 5539-5548. PMID: 18055803
6. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000; 32: 42-50. PMID: 10975909
7. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res.2001; 64: 523-532. PMID: 11391707
8. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol. 2000; 118: 666-673. PMID: 10815159
9. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001; 42: 1787-1794. PMID: 11431443
10. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006; 26: 12633-12641. PMID: 17151265
11. Roh M, Zhang Y, Murakami Y, Thanos A, Lee SC, Vavvas DG, et al. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS one. 2012; 7: e40065. doi: 10.1371/journal.pone.0040065 PMID: 22802951
12. Howell GR, Soto I, Zhu X, Ryan M, Macalinao DG, Sousa GL, et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest. 2012; 122: 1246-1261. doi: 10.1172/JCI61135 PMID: 22426214
13. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997; 337: 1195-1202. PMID: 9337378
14. Rudorfer MV, Manji HK, Potter WZ. Comparative tolerability profiles of the newer versus older antidepressants. Drug Saf. 1994; 10: 18-46. PMID: 8136085
15. Kast RE, Altschuler EL. Remission of Crohn's disease on bupropion. Gastroenterology. 2001; 121: 1260-1261. PMID: 11706830
16. Modell JG, Boyce S, Taylor E, Katholi C. Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study. Psychosom Med. 2002; 64: 835-840. PMID: 12271115
17. Byrne AM, Goleva E, Chouiali F, Kaplan MH, Hamid QA, Leung DY. Induction of GITRL expression in human keratinocytes by Th2 cytokines and TNF-alpha: implications for atopic dermatitis. Clin Exp Allergy 2012; 42: 550-559. doi: 10.1111/j.1365-2222.2012.03956.x PMID: 22417213
18. Peake ST, Bernardo D, Mann ER, Al-Hassi HO, Knight SC, Hart AL. Mechanisms of action of antitumor necrosis factor alpha agents in Crohn's disease. Inflamm Bowel Dis. 2013; 19: 1546-1555. doi: 10.1097/MIB.0b013e318281333b PMID: 23594837
19. Camara-Lemarroy CR, Guzman-de la Garza FJ, Cordero-Perez P, Alarcón-Galván G, Ibarra-Hernández JM, Muñoz-Espinosa LE, et al. Bupropion reduces the inflammatory response and intestinal injury due to ischemia-reperfusion. Transplant Proc. 2013; 45: 2502-2505. doi: 10.1016/j.transproceed.2013.04.010 PMID: 23953570
20. Manosso LM, Neis VB, Moretti M, Daufenbach JF, Freitas AE, Colla AR, et al. Antidepressant-like effect of alpha-tocopherol in a mouse model of depressive-like behavior induced by TNF-alpha. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 46: 48-57. doi: 10.1016/j.pnpbp.2013.06.012 PMID: 23816813
21. Howell GR, Soto I, Ryan M, Graham LC, Smith RS, John SW. Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J Neuroinflammation. 2013; 10: 76. doi: 10.1186/1742-2094-10-76 PMID: 23806181
22. Newman-Casey PA, Talwar N, Nan B, Musch DC, Pasquale LR, Stein JD. The potential association between postmenopausal hormone use and primary open-angle glaucoma. JAMA Ophthalmol. 2014; 132: 298-303. doi: 10.1001/jamaophthalmol.2013.7618 PMID: 24481323
23. Stein JD, Newman-Casey PA, Talwar N, Nan B, Richards JE, Musch DC. The relationship between statin use and open-angle glaucoma. Ophthalmology. 2012; 119: 2074-2081. doi: 10.1016/j.ophtha.2012.04.029 PMID: 22727176
24. Stein JD, Pasquale LR, Talwar N, Kim DS, Reed DM, Nan B, et al. Geographic and climatic factors associated with exfoliation syndrome. Arch Ophthalmol. 2011; 129: 1053-1060. doi: 10.1001/archophthalmol.2011.191 PMID: 21825188
25. Stein JD, Blachley TS, Musch DC. Identification of persons with incident ocular diseases using health care claims databases. Am J Ophthalmol. 2013; 156: 1169-1175. doi: 10.1016/j.ajo.2013.06.035 PMID: 23972306
26. Muir KW, Gupta C, Gill P, Stein JD. Accuracy of international classification of diseases, ninth revision, clinical modification billing codes for common ophthalmic conditions. JAMA Ophthalmol. 2013; 131: 119-120. doi: 10.1001/jamaophthalmol.2013.577 PMID: 23307227
27. Xin X, Gao L, Wu T, Sun F. Roles of tumor necrosis factor gene polymorphisms, tumor necrosis factor alpha level in aqueous humor, and the risk of open-angle glaucoma. Mol Vis 2013; 19: 526-35. PMID: 23559847
28. Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006; 6: 903-907. PMID: 16644475
29. Wu J, Li G, Luna C, Spasojevic I, Epstein DL, Gonzalez P. Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation. Invest Ophthalmol Vis Sci. 2012; 53: 7142-8. doi: 10.1167/iovs.12-9968 PMID: 22997289
30. Wang DY, Ray A, Rodgers K, Ergorul C, Hyman BT, Huang W, Grosskreutz CL. Global gene expression changes in rat retinal ganglion cells in experimental glaucoma. Invest Ophthalmol Vis Sci. 2010; 51: 4084-95. doi: 10.1167/iovs.09-4864 PMID: 20335623
31. Jain R, Majunder P, Gupta T. Pharmacological intervention of nicotine dependence. Biomed Res Int 2013; 2103: 278392 doi: 10.1155/2013/278392 PMID: 24490153
32. Takusagawa HL, Hunter RS, Jue A, Pasquale LR, Chen TC. Bilateral uveal effusion and angle closure glaucoma associated with bupropion use. Arch Ophthalmol 2012; 130:120-22. doi: 10.1001/archopht.130.1.120 PMID: 22232485
33. Edwards R, Thornton J, Ajit R, Harrison RA, Kelly SP. Cigarette smoking and primary open angle glaucoma: a systematic review. J Glaucoma. 2008; 17: 558-566. doi: 10.1097/IJG.0b013e31815f530c PMID: 18854733
34. Wise LA, Rosenberg L, Radin RG, Mattox C, Yang EB, Palmer JR, et al. A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women. Ann Epidemiol. 2011; 21: 430-439. doi: 10.1016/j.annepidem.2011.03.006 PMID: 21549278